CD38 research is expanding; this abstract gives no treatment-benefit estimates
A publication analysis maps growing interest in CD38, a protein involved in cellular metabolism. Its abstract discusses possible clinical uses without reporting measured treatment benefits.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This study maps increasing publication activity around CD38, with the United States and China identified as leading research hubs. Its synthesis discusses the protein's involvement in aging and related diseases. The abstract describes potential clinical applications but provides no measured treatment benefits, so it cannot establish whether targeting this protein improves patients' health.
The abstract omits the literature's size, search period and evidence certainty. This abstract-based explanation cannot assess the supporting studies or determine how much patient-outcome evidence lies behind the proposed clinical applications.
The biological topic
CD38 is a protein that breaks down NAD, a molecule involved in cellular energy metabolism and DNA repair. The review discusses this relationship in aging and disease, but its abstract provides no intervention results demonstrating health benefits.
What publication growth means
The authors identify increasing article numbers, leading research countries and prominent keywords. These observations describe scientific attention and research themes. They do not measure treatment effectiveness, and the abstract does not evaluate the certainty of clinical benefits.
The original publication
Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review.
Zhao X, Lv P, Cai Z et al.
Front Immunol · 2025
- PubMed ID
- 40529366
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.